Call for Application 2022 Opening soon!
Next Roadshow November 17th
Program Duration 9 months
A medical device for non-invasive analysis of embryos in assisted reproduction cycles. It will help doctors choose the most viable embryo to obtain a pregnancy.
If you are in Femtech, Tech4Eva is for you. From great experts giving very relevant advice to other founders in your same boat, it's just a great program.
Working at the Harvard Innovation Lab, Asan developed the world’s highest quality reusable menstrual cup. For every cup they sell, they donate one for free to a woman or girl who cannot afford access to any type of period care.
Named #1 best menstrual cup design globally by London’s evening standard magazine, which we achieved both in 2023 and 2024!
We’ve lifted over 50,000 women out of period poverty, enabling them to go to school and work during periods. We’ve also saved over $10 million household spending on period products and have averted over 200 tons of landfill waste from plastic tampons.
Tech4Eva was the first accelerator I did, when Asan was pre-revenue. It helped me understand the global healthcare market and investment landscape. It was also a great opportunity to refine our business strategy and gain access to a network of individuals who are passionate about driving innovation in Femtech.
Aspivix’s vision is to make “gynecology, now modern” by providing clinicians with women-centric devices designed to advance women’s healthcare globally.
Our flagship product, Carevix™, might reduce pain and bleeding caused by the tenaculum, the current standard of care, to millions of women undergoing office-based gynecological procedures. Carevix delivers gentle cervix handling in all procedures requiring access to the uterus.
Fundraised Series A of $3.75million in 2024 and their cervical stabilizer, #Carevix™, has been named as one of TIME’s Best Inventions of 2024!
Biorithm aims to deliver predictive and personalised maternal & fetal medicine to improve pregnancy experience, birth outcomes and care delivery efficiency. Biorithm’s holistic remote monitoring platform uses a novel medical-grade abdominal ECG wearable and algorithms to offer clinician-prescribed self-monitoring of fetal and maternal heart rate and contractions.
Tech4Eva brings the swiss precision to a growing Femtech industry! We had the opportunity to connect and learn from international key market players, professors from EPFL and most importantly we nurture our passion for women’s health through interaction with a very inspiring community addressing pressing needs in women’s health.
Carbomed Medical Solutions is an Austrian female empowerment tech start-upon a mission to break the taboo which surrounds speaking out about trying to conceive and cycle tracking. breathe ilo is the world’s first fertility tracker that uses breath analysis to identify a woman’s ovulation pattern and fertile window in a way that is easy, comfortable and within one minute. It is a small handheld device synced to an app that reads the breath’s CO2 saturation to determine where a woman is in her cycle with incredible accuracy and can be done at any time of the day.
I am more than happy that I joined the Tech4Eva Accelerator program, because it is a great opportunity to build a network within the Femtech space. I appreciate the great selection of exceptional leaders, founders, mentors and investors. Through the program I got access to particularly valuable knowledge, which brings our start-up to the next level.
CorDiFio is an awareness raising & early-detection AI-powered digital health platform to empower both women & doctors in reaching the right heart disease diagnosis in a timely manner.
As an early stage start-up in the digital health space, the content, network, connections and especially the visibility that Tech4Eva provided us with were second to none. Thanks to Tech4Eva we have met inspiring global entrepreneurs, generous coaches and mentors, investors, and notwithstanding its virtual format new collaborations were started. I trust the creators that Tech4Eva is here to stay to progress the world of Femtech beyond its Swiss borders.
Efelya is an eHealth start-up dedicated to the medical monitoring of pregnancies and the screening of high-risk pregnancies using artificial intelligence and is developing an App for the patients and a Web App for practitioners.
The Tech4Eva program was extremely rich. Coaching, workshop as well as conferences specialized in FemTech allowed us to better understand the challenges of global FemTech and Tech dedicated to obstetrics in particular.
Egyn, a web application will decompartmentalize the journey of cervical cancer screening and ensure faster and more personalized care with an Ai risk assessment algorithm.
Integrating the Early stage Tech4Eva program has clearly accelerated our thinking, also made it possible to anticipate and secure all the critical milestones in this adventure. In addition to the workshops, the coaching sessions allowed us to have specialized follow-up and advice. Thank to the team, speakers and to the coaches and I'm delighted to have been able to participate in this unique program!
By 2025, there will be 1.1 BN women in menopause, suffering from hotflashes. EmbrLabs has harnessed the body’s response to temperature via a wrist-worn bracelet to dramatically affect the impact of menopause symptoms.
$35 million finance round closed in 2023 building on its success
Embr Labs has participated in many accelerators, and the Tech4Eva experience has been one of the most valuable experiences to date. In addition to excellent exposure and mentoring, it is refreshing to participate in a program that is dedicated to the FemTech space to allow companies to accelerate learning and growth.
We plan to disrupt the mental health sector by enabling specifically young women to boost their psychological wellbeing before a mental illness appears. Our approach is based on a motivational journey the user goes through which enhances their mental health. In this unique journey we collect psychological data which enables unique technology-driven insights about the psychological state of a user which has never seen before.
Tech4Eva is a perfect program to connect to international partners. It gives you unique insights into opportunities in different countries and helps you easily connect to the network there.
Fizimed develops connected medical devices for women. 1 woman in 10 is suffering of urinary leaks. Recommended by health professionals, Emy is a connected device to strengthen pelvic floor. Emy allows any woman to do Kegel exercises at home.
The program is an excellent opportunity to gain a better understanding of the rapidly expanding femtech sector. Unlike other programs, since it is directly oriented to our sector, the value of this group is very high.
Gals Bio is leveraging the monthly menstrual secretions to monitor and screen women health from the comfort of home with the accuracy of a lab.
Tech4Eva is an exclusive and invested accelerator with a great agenda of helping the Femtech entrepreneurs and companies to better position and prepare themself for the market and finding funding.
GynTools' revolutionary 5 minute vaginitis diagnostics is replacing current long turnarounds & misdiagnosis. Our solution is disrupting a multi $B market. GYNI allows for correct (>90%) diagnosis within minutes, from a single swab. The system has 4 elements- a smart sample collector, a scanner, web based user interface and a cloud, deep learning based algorithm that analyze the data from the scanner and send back results within seconds.
We graduated from several accelerators. Tech4Eva was the most focused one, very well organized and implemented. Great experience that we recommend to every entrepreneur in the Femhealth field!
Haplomind is a platform that effectively screens, manages and treats global pre and postpartum depression & anxiety. The digital app that can be used by women to be screened, and get support and at the same time for healthcare professionals to remote screen using voice AI and have access to best practices.
Impli CERES focuses on offering a more convenient+effective method of monitoring hormone levels in women receiving infertility treatment. CERES is a subdermal device and a smartphone app, as an alternative to frequent blood tests.
We loved the Tech4Eva program. Our team particularly appreciated the Roadshows and the selection of mentors. They gave us the extra support we needed and helped us build new connections worldwide to pursue our growth.
Kove Medical's device is used at the end of in-utero fetal surgeries to seal the fetal membrane and prevent it to rupture, decreasing the chance for preterm birth. We prevent premature birth following in-utero fetal surgeries.
Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker-based diagnostic solutions for complex diseases. Metabolomic Diagnostics current focus is on pregnancy health, including laboratory test for screening for Preeclampsia risk early in pregnancy.
Tech4Eva provided our team with great insights into the Femtech ecosystem. It was a pleasure to work with the Tech4Eva team who supported the cohort companies. Meeting and connecting with other companies in the same field was something that was very beneficial. We look forward to celebrating the future success of all cohort companies. Thank you Tech4Eva!
MOMM Diagnostics is developing a fast and precise point of care test for preeclampsia - a dangerous pregnancy condition. Our technology will assist doctors on-site to save the lives of of mothers and babies.
MOMM Diagnostics’ novel patented point of care technology allows the quantification of low-abundant biomarkers from a single drop of the mother's blood. MOMM’s rapid preeclampsia test aims at reliable and early-stage molecular diagnosis of PE during doctors’ visits, using low-cost single-use cartridges and a hand-held reader.
Tech4Eva is a great accelerator for companies in FemTech. We benefited from the well-organized program to exchange with peers in the same industry, learn from experienced coaches, and increase our visibility with investors in this field.
A biotech spin-off from UZH with the mission to advance cell therapies for skeletal muscle regeneration, with the first indication: female stress urinary incontinence.
Fantastic top-organized program, allowing for a very broad view on the FemTech ecosystem and current developments, with world-class coaches, giving brilliant advice! Thanks for the honour to have been selected for this journey!
Bringing the endocrine system into the 21st century with a perimenopause/menopause management app (mySysters) to give consumers the best outcome per healthcare dollar : mySysters combines symptom tracking with content and community to give busy women data driven information, higher quality medical visits and improve clinical outcomes.
Tech4Eva allows us and other FemTech founders to openly discuss our products. In other forums or accelerators, people blush or cringe if we use anything other than quaint euphemisms for the female anatomy.
PhenomX is a precision nutrition for women company focused on using the latest non-invasive technologies to measure hormonal health imbalances and aging and provide therapeutic nutrition solutions.
An excellent program to support my company’s early needs to reach the point of seed funding.
Preglife is a HealthTech company focused creating the best pregnancy- postpartum and baby app. Preglife's mission is to maximize the conditions for all parents to be. You follow the development during the pregnancy, post partum period and toddler up to 2 years. We are now in the process of developing personalized content and programs to the user based on her medical history and current symptoms and mood.
A smartphone-compatible pregnancy-style urine self-test that provides results in minutes for the four common sexually transmitted diseases (chlamydia, gonorrhoea, trichomoniasis & mycoplasma) without having to send samples to a lab.
Fundraised $6.2 Million in 2023
1st non-invasive blood test in the World, with instant results! We present a menstrual pad, called "Truelli-Dia", that has the ability to detect: Vitamin Deficiencies, Infertility, STDs, Cancer affiliated biomarkers and alert the user via our barcode reader mobile App.
Tech4Eva program opened doors & markets that we didn't think of before!
Contrelle Activgard is a Class IIa medical device for female stress urinary incontinence. It is a disposable and discreet bladder support which is designed to stop leaks before they happen.
Viveva-biomed has achieved a significant trading business in the UK and now has 25 export markets trading with distributor partnerships in place. They recently achieved another major milestone in gaining acceptance to the UK drug tariff meaning GP’s can prescribe the product – and helped their partner in Norway achieve reimbursement. Everyone told them that it would be impossible to get the NHS approval so they took a non-conventional approach! In March 2023, they won one of the prestigious UK healthcare awards as start up of the year.
The program provides unique insights and opportunities which are not available elsewhere. The drive of the team running Tech4Eva is exceptional in helping the delivery of a broad program of activity across multiple subjects. It is only when you start engaging and understanding the support, material and contacts available is when you appreciate the value.
Vulvae is the 1st digital health journal, 100% dedicated to vulvas’ health. The app will provide pain tracking tools, informative contents and personalised guidance for anyone experiencing vulvar pain, currently on a diagnosis and/or treatment pathway. Through the app’, we aim at revolutionising the wellbeing and health of all vulvas, and free them from all their pain. Vulvae, the new way to take care of your vulva.
I was truly challenged by my Tech4Eva coach and it led me to tackling subjects with more exigence I would have, by myself. I learnt a lot on the medical side of building a FemTech start-up and it was stimulating to be part of a group of inspiring start-ups.
Radically regenerative, exploitation-free and green period products made from seaweed. We want to produce innovative period products from algae to prove product-excellence, radical sustainability and empowerment can go hand in hand. Our products shall not only empower women and reframe the social stigma associated with periods, but they will also be trailblazers for a circular economy in accordance with nature - leveraging the incredible potential of algae.
Programs like Tech4Eva are a super important contribution to gender equality. Female health has been neglected for much too long and every support that founders of FemTech start-ups can get will help to close the gender health gap. Innovation in the field needs to be supported, promoted and made visible at all levels. We are very grateful for the support we receive from Tech4Eva and the mutually supportive community of fellow FemTech pioneers!
WOOM is a women’s health tracker, assisting Women during the different stages of their lives: tracking cycles and prevention, trying to conceive, pregnancy, postpartum up to menopause. It's all about data science, we collect+100 parameters of user’s lifestyle, cycle, health and biometrics data to provide personalized recommendations, empowering women to make the right decisions about their reproductive health through a robust set of data and technology based on neural networks & machine learning. WOOM algorithms forecast women's cycles, fertility windows, chances of pregnancy and serves personalized content. Women supports each others through our active community.
Woom was acquired by the world's 1st virtual fertility clinic Apricity in May 2022.
Very focused program and a must do for FemTech start-ups, get the global perspective with contacts from Asia, Europe and US.
Yeda medical device has a silicon form that individually inflates inside the vagina to treat pelvic organ prolapse and incontinence immediately. While the organs are held in a healthy position, the pelvic muscles are trained over the app.
Tech4Eva was an excellent program for us to understand better the FemTech environment. It felt like we were all working together towards a common goal of offering better solutions for women's health. The feeling that Tech4Eva created is that there is enough space for all of us and that we are the ones shaping this new emerging industry.
Vaginal microbiome analysis for women wanting to improve their chances of In-vitro fertilisation.
Partnerships with prominent clinics in Switzerland allowing us to reach more women and provide them with targeted, scientifically-backed solutions. And a collaboration with partners in China to expand our reach by selling our product online enabled us to introduce YONI Solutions to a broader international market, further validating the demand for personalized vaginal health solutions.
Tech4Eva has been important in helping us connect with other innovators, researchers, and investors who share our mission of advancing women’s health. We’ve gained valuable insights and ways to enhance our work in women’s health space. Additionally, the exposure to events and direct contact with experienced entrepreneurs has been very special for me, especially as It has allowed me to better understand the entrepreneurial world in the Femtech.
Biorithm aims to deliver predictive and personalised maternal & fetal medicine to improve pregnancy experience, birth outcomes and care delivery efficiency. Biorithm’s holistic remote monitoring platform uses a novel medical-grade abdominal ECG wearable and algorithms to offer clinician-prescribed self-monitoring of fetal and maternal heart rate and contractions.
Tech4Eva brings the swiss precision to a growing Femtech industry! We had the opportunity to connect and learn from international key market players, professors from EPFL and most importantly we nurture our passion for women’s health through interaction with a very inspiring community addressing pressing needs in women’s health.
Efelya is an eHealth start-up dedicated to the medical monitoring of pregnancies and the screening of high-risk pregnancies using artificial intelligence and is developing an App for the patients and a Web App for practitioners.
The Tech4Eva program was extremely rich. Coaching, workshop as well as conferences specialized in FemTech allowed us to better understand the challenges of global FemTech and Tech dedicated to obstetrics in particular.
Fizimed develops connected medical devices for women. 1 woman in 10 is suffering of urinary leaks. Recommended by health professionals, Emy is a connected device to strengthen pelvic floor. Emy allows any woman to do Kegel exercises at home.
The program is an excellent opportunity to gain a better understanding of the rapidly expanding femtech sector. Unlike other programs, since it is directly oriented to our sector, the value of this group is very high.
Haplomind is a platform that effectively screens, manages and treats global pre and postpartum depression & anxiety. The digital app that can be used by women to be screened, and get support and at the same time for healthcare professionals to remote screen using voice AI and have access to best practices.
Kove Medical's device is used at the end of in-utero fetal surgeries to seal the fetal membrane and prevent it to rupture, decreasing the chance for preterm birth. We prevent premature birth following in-utero fetal surgeries.
Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker-based diagnostic solutions for complex diseases. Metabolomic Diagnostics current focus is on pregnancy health, including laboratory test for screening for Preeclampsia risk early in pregnancy.
Tech4Eva provided our team with great insights into the Femtech ecosystem. It was a pleasure to work with the Tech4Eva team who supported the cohort companies. Meeting and connecting with other companies in the same field was something that was very beneficial. We look forward to celebrating the future success of all cohort companies. Thank you Tech4Eva!
MOMM Diagnostics is developing a fast and precise point of care test for preeclampsia - a dangerous pregnancy condition. Our technology will assist doctors on-site to save the lives of of mothers and babies.
MOMM Diagnostics’ novel patented point of care technology allows the quantification of low-abundant biomarkers from a single drop of the mother's blood. MOMM’s rapid preeclampsia test aims at reliable and early-stage molecular diagnosis of PE during doctors’ visits, using low-cost single-use cartridges and a hand-held reader.
Tech4Eva is a great accelerator for companies in FemTech. We benefited from the well-organized program to exchange with peers in the same industry, learn from experienced coaches, and increase our visibility with investors in this field.
Preglife is a HealthTech company focused creating the best pregnancy- postpartum and baby app. Preglife's mission is to maximize the conditions for all parents to be. You follow the development during the pregnancy, post partum period and toddler up to 2 years. We are now in the process of developing personalized content and programs to the user based on her medical history and current symptoms and mood.
A biotech spin-off from UZH with the mission to advance cell therapies for skeletal muscle regeneration, with the first indication: female stress urinary incontinence.
Fantastic top-organized program, allowing for a very broad view on the FemTech ecosystem and current developments, with world-class coaches, giving brilliant advice! Thanks for the honour to have been selected for this journey!
PhenomX is a precision nutrition for women company focused on using the latest non-invasive technologies to measure hormonal health imbalances and aging and provide therapeutic nutrition solutions.
An excellent program to support my company’s early needs to reach the point of seed funding.
1st non-invasive blood test in the World, with instant results! We present a menstrual pad, called "Truelli-Dia", that has the ability to detect: Vitamin Deficiencies, Infertility, STDs, Cancer affiliated biomarkers and alert the user via our barcode reader mobile App.
Tech4Eva program opened doors & markets that we didn't think of before!
Contrelle Activgard is a Class IIa medical device for female stress urinary incontinence. It is a disposable and discreet bladder support which is designed to stop leaks before they happen.
Viveva-biomed has achieved a significant trading business in the UK and now has 25 export markets trading with distributor partnerships in place. They recently achieved another major milestone in gaining acceptance to the UK drug tariff meaning GP’s can prescribe the product – and helped their partner in Norway achieve reimbursement. Everyone told them that it would be impossible to get the NHS approval so they took a non-conventional approach! In March 2023, they won one of the prestigious UK healthcare awards as start up of the year.
The program provides unique insights and opportunities which are not available elsewhere. The drive of the team running Tech4Eva is exceptional in helping the delivery of a broad program of activity across multiple subjects. It is only when you start engaging and understanding the support, material and contacts available is when you appreciate the value.
Vulvae is the 1st digital health journal, 100% dedicated to vulvas’ health. The app will provide pain tracking tools, informative contents and personalised guidance for anyone experiencing vulvar pain, currently on a diagnosis and/or treatment pathway. Through the app’, we aim at revolutionising the wellbeing and health of all vulvas, and free them from all their pain. Vulvae, the new way to take care of your vulva.
I was truly challenged by my Tech4Eva coach and it led me to tackling subjects with more exigence I would have, by myself. I learnt a lot on the medical side of building a FemTech start-up and it was stimulating to be part of a group of inspiring start-ups.
Yeda medical device has a silicon form that individually inflates inside the vagina to treat pelvic organ prolapse and incontinence immediately. While the organs are held in a healthy position, the pelvic muscles are trained over the app.
Tech4Eva was an excellent program for us to understand better the FemTech environment. It felt like we were all working together towards a common goal of offering better solutions for women's health. The feeling that Tech4Eva created is that there is enough space for all of us and that we are the ones shaping this new emerging industry.
Working at the Harvard Innovation Lab, Asan developed the world’s highest quality reusable menstrual cup. For every cup they sell, they donate one for free to a woman or girl who cannot afford access to any type of period care.
Named #1 best menstrual cup design globally by London’s evening standard magazine, which we achieved both in 2023 and 2024!
We’ve lifted over 50,000 women out of period poverty, enabling them to go to school and work during periods. We’ve also saved over $10 million household spending on period products and have averted over 200 tons of landfill waste from plastic tampons.
Tech4Eva was the first accelerator I did, when Asan was pre-revenue. It helped me understand the global healthcare market and investment landscape. It was also a great opportunity to refine our business strategy and gain access to a network of individuals who are passionate about driving innovation in Femtech.
Gals Bio is leveraging the monthly menstrual secretions to monitor and screen women health from the comfort of home with the accuracy of a lab.
Tech4Eva is an exclusive and invested accelerator with a great agenda of helping the Femtech entrepreneurs and companies to better position and prepare themself for the market and finding funding.
GynTools' revolutionary 5 minute vaginitis diagnostics is replacing current long turnarounds & misdiagnosis. Our solution is disrupting a multi $B market. GYNI allows for correct (>90%) diagnosis within minutes, from a single swab. The system has 4 elements- a smart sample collector, a scanner, web based user interface and a cloud, deep learning based algorithm that analyze the data from the scanner and send back results within seconds.
We graduated from several accelerators. Tech4Eva was the most focused one, very well organized and implemented. Great experience that we recommend to every entrepreneur in the Femhealth field!
Radically regenerative, exploitation-free and green period products made from seaweed. We want to produce innovative period products from algae to prove product-excellence, radical sustainability and empowerment can go hand in hand. Our products shall not only empower women and reframe the social stigma associated with periods, but they will also be trailblazers for a circular economy in accordance with nature - leveraging the incredible potential of algae.
Programs like Tech4Eva are a super important contribution to gender equality. Female health has been neglected for much too long and every support that founders of FemTech start-ups can get will help to close the gender health gap. Innovation in the field needs to be supported, promoted and made visible at all levels. We are very grateful for the support we receive from Tech4Eva and the mutually supportive community of fellow FemTech pioneers!
A medical device for non-invasive analysis of embryos in assisted reproduction cycles. It will help doctors choose the most viable embryo to obtain a pregnancy.
If you are in Femtech, Tech4Eva is for you. From great experts giving very relevant advice to other founders in your same boat, it's just a great program.
Aspivix’s vision is to make “gynecology, now modern” by providing clinicians with women-centric devices designed to advance women’s healthcare globally.
Our flagship product, Carevix™, might reduce pain and bleeding caused by the tenaculum, the current standard of care, to millions of women undergoing office-based gynecological procedures. Carevix delivers gentle cervix handling in all procedures requiring access to the uterus.
Fundraised Series A of $3.75million in 2024 and their cervical stabilizer, #Carevix™, has been named as one of TIME’s Best Inventions of 2024!
Carbomed Medical Solutions is an Austrian female empowerment tech start-upon a mission to break the taboo which surrounds speaking out about trying to conceive and cycle tracking. breathe ilo is the world’s first fertility tracker that uses breath analysis to identify a woman’s ovulation pattern and fertile window in a way that is easy, comfortable and within one minute. It is a small handheld device synced to an app that reads the breath’s CO2 saturation to determine where a woman is in her cycle with incredible accuracy and can be done at any time of the day.
I am more than happy that I joined the Tech4Eva Accelerator program, because it is a great opportunity to build a network within the Femtech space. I appreciate the great selection of exceptional leaders, founders, mentors and investors. Through the program I got access to particularly valuable knowledge, which brings our start-up to the next level.
Impli CERES focuses on offering a more convenient+effective method of monitoring hormone levels in women receiving infertility treatment. CERES is a subdermal device and a smartphone app, as an alternative to frequent blood tests.
We loved the Tech4Eva program. Our team particularly appreciated the Roadshows and the selection of mentors. They gave us the extra support we needed and helped us build new connections worldwide to pursue our growth.
WOOM is a women’s health tracker, assisting Women during the different stages of their lives: tracking cycles and prevention, trying to conceive, pregnancy, postpartum up to menopause. It's all about data science, we collect+100 parameters of user’s lifestyle, cycle, health and biometrics data to provide personalized recommendations, empowering women to make the right decisions about their reproductive health through a robust set of data and technology based on neural networks & machine learning. WOOM algorithms forecast women's cycles, fertility windows, chances of pregnancy and serves personalized content. Women supports each others through our active community.
Woom was acquired by the world's 1st virtual fertility clinic Apricity in May 2022.
Very focused program and a must do for FemTech start-ups, get the global perspective with contacts from Asia, Europe and US.
Vaginal microbiome analysis for women wanting to improve their chances of In-vitro fertilisation.
Partnerships with prominent clinics in Switzerland allowing us to reach more women and provide them with targeted, scientifically-backed solutions. And a collaboration with partners in China to expand our reach by selling our product online enabled us to introduce YONI Solutions to a broader international market, further validating the demand for personalized vaginal health solutions.
Tech4Eva has been important in helping us connect with other innovators, researchers, and investors who share our mission of advancing women’s health. We’ve gained valuable insights and ways to enhance our work in women’s health space. Additionally, the exposure to events and direct contact with experienced entrepreneurs has been very special for me, especially as It has allowed me to better understand the entrepreneurial world in the Femtech.
By 2025, there will be 1.1 BN women in menopause, suffering from hotflashes. EmbrLabs has harnessed the body’s response to temperature via a wrist-worn bracelet to dramatically affect the impact of menopause symptoms.
$35 million finance round closed in 2023 building on its success
Embr Labs has participated in many accelerators, and the Tech4Eva experience has been one of the most valuable experiences to date. In addition to excellent exposure and mentoring, it is refreshing to participate in a program that is dedicated to the FemTech space to allow companies to accelerate learning and growth.
Bringing the endocrine system into the 21st century with a perimenopause/menopause management app (mySysters) to give consumers the best outcome per healthcare dollar : mySysters combines symptom tracking with content and community to give busy women data driven information, higher quality medical visits and improve clinical outcomes.
Tech4Eva allows us and other FemTech founders to openly discuss our products. In other forums or accelerators, people blush or cringe if we use anything other than quaint euphemisms for the female anatomy.
We plan to disrupt the mental health sector by enabling specifically young women to boost their psychological wellbeing before a mental illness appears. Our approach is based on a motivational journey the user goes through which enhances their mental health. In this unique journey we collect psychological data which enables unique technology-driven insights about the psychological state of a user which has never seen before.
Tech4Eva is a perfect program to connect to international partners. It gives you unique insights into opportunities in different countries and helps you easily connect to the network there.
CorDiFio is an awareness raising & early-detection AI-powered digital health platform to empower both women & doctors in reaching the right heart disease diagnosis in a timely manner.
As an early stage start-up in the digital health space, the content, network, connections and especially the visibility that Tech4Eva provided us with were second to none. Thanks to Tech4Eva we have met inspiring global entrepreneurs, generous coaches and mentors, investors, and notwithstanding its virtual format new collaborations were started. I trust the creators that Tech4Eva is here to stay to progress the world of Femtech beyond its Swiss borders.
Egyn, a web application will decompartmentalize the journey of cervical cancer screening and ensure faster and more personalized care with an Ai risk assessment algorithm.
Integrating the Early stage Tech4Eva program has clearly accelerated our thinking, also made it possible to anticipate and secure all the critical milestones in this adventure. In addition to the workshops, the coaching sessions allowed us to have specialized follow-up and advice. Thank to the team, speakers and to the coaches and I'm delighted to have been able to participate in this unique program!
A smartphone-compatible pregnancy-style urine self-test that provides results in minutes for the four common sexually transmitted diseases (chlamydia, gonorrhoea, trichomoniasis & mycoplasma) without having to send samples to a lab.
Fundraised $6.2 Million in 2023